IL17A and infection: To determine whether continued neutralization of IL-17 throughout the peak of infection would significantly increase bacterial loads, mice infected with 5×105 CFU WT were treated with 100 μg of α-IL-17 monoclonal antibody (or rat IgG control antibody) on days 3, 5 and 7 post-infection and bacterial loads were assessed on day 8.